Giotrif 50 mg Iordania - engleză - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

giotrif 50 mg

شركة مستودع الادوية العربي - the arab drug store p.s.c - afatinib 50 mg - 50 mg

Afatin 40 40 mg Film-Coated Tablet Filipine - engleză - FDA (Food And Drug Administration)

afatin 40 40 mg film-coated tablet

camber pharmaceuticals, inc.; distributor: camber pharmaceuticals, inc. - afatinib (as dim aleate) - film-coated tablet - 40 mg

Giotrif Tablets 20mg (ジオトリフ錠20mg) Japonia - engleză - すりの適正使用協議会 RAD-AR Council, Japan

giotrif tablets 20mg (ジオトリフ錠20mg)

nippon boehringer ingelheim co., ltd. - afatinib maleate - white to slightly yellowish white tablet, diameter: ca. 8.1 mm, thickness: ca. 3.6 mm

Giotrif Tablets 30mg (ジオトリフ錠30mg) Japonia - engleză - すりの適正使用協議会 RAD-AR Council, Japan

giotrif tablets 30mg (ジオトリフ錠30mg)

nippon boehringer ingelheim co., ltd. - afatinib maleate - dark blue tablet, diameter: ca. 9.1 mm, thickness: ca. 4.1 mm

Giotrif Tablets 40mg (ジオトリフ錠40mg) Japonia - engleză - すりの適正使用協議会 RAD-AR Council, Japan

giotrif tablets 40mg (ジオトリフ錠40mg)

nippon boehringer ingelheim co., ltd. - afatinib maleate - light blue tablet, diameter: ca. 10.1 mm, thickness: ca. 4.5 mm

Lopinavir/Ritonavir Mylan Uniunea Europeană - engleză - EMA (European Medicines Agency)

lopinavir/ritonavir mylan

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Lopinavir/Ritonavir Mylan Uniunea Europeană - engleză - EMA (European Medicines Agency)

lopinavir/ritonavir mylan

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

LOPINAVIR/RITONAVIR SANDOZ Irlanda - engleză - HPRA (Health Products Regulatory Authority)

lopinavir/ritonavir sandoz

rowex ltd - lopinavir (amorphous); ritonavir - film coated tablet - 200/50 milligram - direct acting antivirals